2 years ago
ARQT
AnalystsUy EarUy Ear's Stock Forecasts
AnalystsUy Ear
Analyst Ranking
Top 33%
#1645 out of 4997 analysts
Average Return
+2.02%
Win Rate
42%18 out of 43
Risk vs Reward
Poor
Good
Uy Ear's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | +306.12% | $3.43 | $13.93 | 2024-01-02 - 2024-12-31 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +272.38% | $3.91 | $14.56 | 2024-01-03 - 2025-01-02 | Strong Buy |
Cabaletta Bio IncCABA | +131.36% | $8.10 | $18.74 | 2023-03-17 - 2024-03-15 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +47.19% | $9.24 | $13.60 | 2024-05-15 - 2025-05-14 | Strong Buy |
Evolus IncEOLS | +41.71% | $8.75 | $12.40 | 2023-06-07 - 2024-06-06 | Strong Buy |
Uy Ear Analyst Color
Get additional color on Uy Ear's coverage of popular stocks
Uy Ear's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Acadia Pharmaceuticals IncACAD | 13 | Hold | $24.00 | -5.21% | Maintains | 19 days ago |
Mbx Biosciences IncMBX | 1 | Buy | $38.00 | +173.58% | Initiates Coverage On | 22 days ago |
Sarepta Therapeutics IncSRPT | 7 | Hold | $14.00 | -22.48% | Downgrades | a month ago |
Tectonic Therapeutic IncTECX | 6 | Buy | $85.00 | +245.95% | Maintains | 3 months ago |
Arcutis Biotherapeutics IncARQT | 13 | Buy | $21.00 | +33.84% | Maintains | 6 months ago |
Uniqure NvQURE | 4 | Hold | $20.00 | +28.62% | Maintains | 8 months ago |
Relmada Therapeutics IncRLMD | 1 | Hold | $1.00 | +60.26% | Downgrades | 9 months ago |
Alkermes PLCALKS | 5 | Buy | $40.00 | +37.93% | Maintains | 9 months ago |
Sage Therapeutics IncSAGE | 2 | Hold | $16.00 | N/A | Maintains | a year ago |
Cartesian Therapeutics IncRNAC | 3 | Strong Buy | $40.00 | N/A | Initiates Coverage On | a year ago |
Evolus IncEOLS | 3 | Strong Buy | $23.00 | N/A | Maintains | a year ago |
Neurocrine Biosciences IncNBIX | 9 | Hold | $140.00 | N/A | Maintains | 2 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Johnson & JohnsonJNJ | 1 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Satsuma Pharmaceuticals IncSTSA | 1 | Hold | $2.00 | N/A | Reiterates | 2 years ago |
Cabaletta Bio IncCABA | 1 | Strong Buy | $10.00 | N/A | Reiterates | 2 years ago |
Ocugen IncOCGN | 2 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.